Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA BMurphy5@partners.org Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA Harvard Medical School Boston, MA and Laboratory for Psychiatric Biostatistics McLean Hospital Belmont, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA.
Beth L
BL
Murphy
Suzann M
SM
Babb
Caitlin
C
Ravichandran
Bruce M
BM
Cohen
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
D000928:Antidepressive Agents; D012436:S-Adenosylmethionine